2452 related articles for article (PubMed ID: 16543533)
1. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
2. Association study of cathepsin D gene polymorphism in Iranian patients with sporadic late-onset Alzheimer's disease.
Sayad A; Noruzinia M; Zamani M; Harirchian MH; Kazemnejad A
Dement Geriatr Cogn Disord; 2014; 37(5-6):257-64. PubMed ID: 24281128
[TBL] [Abstract][Full Text] [Related]
3. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
5. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
6. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
7. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
8. Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.
Mann DMA; Davidson YS; Robinson AC; Allen N; Hashimoto T; Richardson A; Jones M; Snowden JS; Pendleton N; Potier MC; Laquerrière A; Prasher V; Iwatsubo T; Strydom A
Acta Neuropathol; 2018 Oct; 136(4):569-587. PubMed ID: 29770843
[TBL] [Abstract][Full Text] [Related]
9. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
10. Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
Mann DM; Iwatsubo T; Pickering-Brown SM; Owen F; Saido TC; Perry RH
Neurosci Lett; 1997 Jan; 221(2-3):81-4. PubMed ID: 9121705
[TBL] [Abstract][Full Text] [Related]
11. The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Mastroianni F; Liaci M; Vendemiale G; Capurso A; Panza F
J Gerontol A Biol Sci Med Sci; 2005 Aug; 60(8):991-6. PubMed ID: 16127101
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid levels of beta-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D gene.
Papassotiropoulos A; Lewis HD; Bagli M; Jessen F; Ptok U; Schulte A; Shearman MS; Heun R
Neuroreport; 2002 Jul; 13(10):1291-4. PubMed ID: 12151789
[TBL] [Abstract][Full Text] [Related]
13. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.
McNamara MJ; Gomez-Isla T; Hyman BT
Arch Neurol; 1998 Jul; 55(7):1001-4. PubMed ID: 9678319
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly.
Walker LC; Pahnke J; Madauss M; Vogelgesang S; Pahnke A; Herbst EW; Stausske D; Walther R; Kessler C; Warzok RW
Acta Neuropathol; 2000 Jul; 100(1):36-42. PubMed ID: 10912918
[TBL] [Abstract][Full Text] [Related]
16. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
[TBL] [Abstract][Full Text] [Related]
17. A 3'-UTR polymorphism in the oxidized LDL receptor 1 gene increases Abeta40 load as cerebral amyloid angiopathy in Alzheimer's disease.
Shi J; Tian J; Pritchard A; Lendon C; Lambert JC; Iwatsubo T; Mann DM
Acta Neuropathol; 2006 Jan; 111(1):15-20. PubMed ID: 16328515
[TBL] [Abstract][Full Text] [Related]
18. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
[TBL] [Abstract][Full Text] [Related]
19. Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?
Lambert JC; Mann D; Richard F; Tian J; Shi J; Thaker U; Merrot S; Harris J; Frigard B; Iwatsubo T; Lendon C; Amouyel P
J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):928-33. PubMed ID: 15965197
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease.
Lendon CL; Thaker U; Harris JM; McDonagh AM; Lambert JC; Chartier-Harlin MC; Iwatsubo T; Pickering-Brown SM; Mann DM
Neurosci Lett; 2002 Aug; 328(3):314-8. PubMed ID: 12147333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]